Excellent Medical Technology Group Co (BJSE:920050) EBIT: ¥113 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920050 Excellent Medical Technology Group Co Ltd BJSE:920050
17 GF Score
Price ¥28.75
! 3 Warning Signs
View Full Analysis

What is Excellent Medical Technology Group Co EBIT?

Excellent Medical Technology Group Co BJSE:920050 17 EBIT is ¥113 Mil as of Jun. 2026. GuruFocus rates BJSE:920050 with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

Excellent Medical Technology Group Co's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2026 was ¥38 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was ¥113 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Excellent Medical Technology Group Co's annualized ROC % for the quarter that ended in Jun. 2026 was 18.24%. Excellent Medical Technology Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 15.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Excellent Medical Technology Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 5.45%.

Excellent Medical Technology Group Co  (BJSE:920050) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Excellent Medical Technology Group Co's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=240.276 * ( 1 - 0.16% )/( (1311.002 + 1319.211)/ 2 )
=239.8915584/1315.1065
=18.24 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1641.712 - 161.614 - ( 362.836 - max(0, 492.819 - 661.915+362.836))
=1311.002

Invested Capital(Q: Jun. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1610.421 - 213.003 - ( 207.31 - max(0, 521.745 - 599.952+207.31))
=1319.211

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Excellent Medical Technology Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=151.36/( ( (798.94 + max(128.376, 0)) + (822.213 + max(167.876, 0)) )/ 2 )
=151.36/( ( 927.316 + 990.089 )/ 2 )
=151.36/958.7025
=15.79 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(59.292 + 192.523 + 40.741) - (161.614 + 0 + 2.566)
=128.376

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(100.925 + 236.324 + 46.443) - (213.003 + 0 + 2.813)
=167.876

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Excellent Medical Technology Group Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2026 )
=113.018/2072.758
=5.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Excellent Medical Technology Group Co EBIT Related Terms

Excellent Medical Technology Group Co EBIT Historical Data

* Premium members only.

The historical data trend for Excellent Medical Technology Group Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Excellent Medical Technology Group Co EBIT Chart

Excellent Medical Technology Group Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
129.59 82.43 90.87 102.90 107.42

Excellent Medical Technology Group Co Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.61 632.05 -582.20 25.33 37.84

BJSE:920050 vs ISRG, BDX, RMD: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Excellent Medical Technology Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Excellent Medical Technology Group Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Excellent Medical Technology Group Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Excellent Medical Technology Group Co's EV-to-EBIT falls into.


BJSE:920050
17GF Score
Excellent Medical Technology Group Co Ltd BJSE:920050
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Excellent Medical Technology Group Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥113 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ¥113 Mil mean?
Excellent Medical Technology Group Co (BJSE:920050) has a EBIT of ¥113 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Excellent Medical Technology Group Co.
Is Excellent Medical Technology Group Co's EBIT too high?
Excellent Medical Technology Group Co's current EBIT is ¥113 Mil. Overall, Excellent Medical Technology Group Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Excellent Medical Technology Group Co's EBIT compare to ISRG and BDX?
Excellent Medical Technology Group Co's EBIT of ¥113 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Excellent Medical Technology Group Co. Excellent Medical Technology Group Co's current EBIT is ¥113 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excellent Medical Technology Group Co stock overvalued right now?
Excellent Medical Technology Group Co (BJSE:920050) has a current EBIT of ¥113 Mil. The current EBIT is ¥113 Mil. Excellent Medical Technology Group Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Excellent Medical Technology Group Co (BJSE:920050), the current EBIT is ¥113 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Excellent Medical Technology Group Co Business Description

Address No. 1539, Xiangcheng Avenue, Yuanhe Street, Room 2004, 23rd Floor, Xiangcheng District, Jiangsu Province, Suzhou, CHN, 215131
Excellent Medical Technology Group Co Ltd is engaged in the research, development, production, and sale of disposable medical consumables. Its products are used in professional rehabilitation care and medical protection applications.
17GF Score

Get the complete analysis for BJSE:920050

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.75
Price